期刊文献+

阿尔茨海默病患者血清IL-10和sIL-6R水平的变化 被引量:1

The Alteration of Serum Interleukin-10 and Soluble Interleukin-6 Receptor Levels in Patients with Alzheimer Disease
下载PDF
导出
摘要 目的探讨阿尔茨海默病(Alzheimerdisease,AD)患者血清白细胞介素10(interleukin10,IL10)、可溶性白细胞介素6受体(solubleinterleukin6receptor,sIL6R)水平变化及其与痴呆严重程度的关系。方法采用双抗体夹心ELISA法检测46例AD患者(AD组)、33名年龄匹配健康者(对照组)和40例脑梗死患者(CI组)血清IL10、sIL6R水平。结果AD患者血清IL10水平较正常对照组和CI组均明显降低,但对照组与CI组间差异无显著性。AD患者血清sIL6R水平较正常对照组明显升高并随痴呆程度加重而不断上升;CI组中血清sIL6R水平也明显高于对照组,但AD组和CI组间差异无显著性。结论AD患者血清IL10和sIL6R水平的变化提示免疫炎性机制参与了AD的发病。 Objective To investigate the level of interleukin-10 (IL-10) and soluble interleukin-6 receptor(sIL-6R) in serum of patients with Alzheimer disease (AD) and its correlation with severity of AD. Methods The concentrations of serum IL-10 and sIL-6R were measured by means of an enzyme-linked immunosorbent assay in 46 AD patients, 40 cerebral infarction (CI) patients and 33 healthy control subjects. Results The level of IL-10 was significantly decreased in AD patients, compared with both CI patients and healthy control subjects, but did not differ between CI patients and healthy control subjects. sIL-6R content was significantly increased in AD (patients,) especially in the severe AD patients, No statistical difference in the concentration of sIL-6R was noted between AD patients and CI patients. Conclusions Alteration of serum IL-10 and sIL-6R levels are found in AD patients, demonstrating that inflammation is involved in the pathological process of AD.
出处 《中国神经免疫学和神经病学杂志》 CAS 2005年第4期216-218,246,共4页 Chinese Journal of Neuroimmunology and Neurology
关键词 阿尔茨海默病 脑梗死 炎性反应 白细胞介素-10 可溶性白细胞介素-6受体 Alzheimer disease cerebral infarction inflammation interleukin-10 interleukin-6 receptor
  • 相关文献

参考文献9

  • 1吴传深,周东丰,管振全.血浆IL-6水平与阿尔茨海默病[J].中国神经免疫学和神经病学杂志,2003,10(2):87-89. 被引量:8
  • 2Sala G. Periphral cytokine release in Alzheimer patients:correlation with disease severity[J]. Neurobiol Aging, 2003,24:909-914. 被引量:1
  • 3Federico L. Increased plasma levels of interleukin-1,interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? [J]. J Neuroimmunol,2000,103(1):97-102. 被引量:1
  • 4孔庆利,张建民,张振馨,葛平江,徐亚君,秘汝顺,赵玉华,隋延萍,何维.阿尔茨海默病患者血清中巨噬细胞集落刺激因子[J].中国医学科学院学报,2002,24(3):298-301. 被引量:2
  • 5Bagli M, Papassotiropoulos A, Hampel H, et al. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease[J]. Eur Arch Psychiatry Clin Neurosci,2003, 253:44-48. 被引量:1
  • 6De Luigi A, Pizzimenti S, Quadri P, et al. Peripheral Inflammatory response in Alzheimer's disease and multiinfarct dementia [J].Neurobiol Dis ,2002,11:308-314. 被引量:1
  • 7Szczepanik AM. IL-4, IL-10 and IL-13 modulate Aβ1-42 induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line[J]. J Neuroimmunol, 2001,113(1):49-62. 被引量:1
  • 8Hawkins DL,Mackay RJ,Mackay SL, et al. Human TGF-beta and interleukin-10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages[J]. Vet Immunol Immunopathol,1998,66:1-10. 被引量:1
  • 9Beloosesky Y, Salman H, Bergman M, et al. Cytokine levels and phagocytic activity in patients with Alzheimer's disease[J]. Gerontology,2002,48:128-132. 被引量:1

二级参考文献20

  • 1[1]Ensoli F, Fiorelli V, Muratori DS, et al. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators? Crit Rev Immuno,1999, 19:97-116 被引量:1
  • 2[2]Akiyama H, Nishimura T, Kondo H, et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res, 1994, 639:171-174 被引量:1
  • 3[3]McGeer PL, Akiyama H, Itagaki S, et al. Immune systemresponse in Alzheimer's disease. J Neurol Sci, 1989, 16:516-527 被引量:1
  • 4[4]McGeer PI, Itagaki S, Tago H, et al. Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett, 1987, 79:195-200 被引量:1
  • 5[5]Tarkowski E, Blennow K, Wallin A, et al. Intracerebral production tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer's disease and vascular dementia. JClin Immunol, 1999, 19:223-230 被引量:1
  • 6[6]Murphy GM, Zhao FF, Yang L, et al. Expression of mac rophage colony-stimulating factor receptor is increased inthe AβPPv717F transgenic mouse model of Alzheimer'sdisease. Am J Pathol, 2000, 157:895-904 被引量:1
  • 7[7]Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology, 1994, 44:227-232 被引量:1
  • 8[8]Bonaccorso S, Lin A, Song C, et al. serotonine-immune interactions in elderly volunteers and in patients with Alzheimer's disease(DAT): lower plasma tryptophan availab ility to the brain in elderly and increased serum interleukine-6 in DAT. Aging (Milano) , 1998, 10:316-323 被引量:1
  • 9[9]Yan SD, Zhu HJ, Fu J, et al. Amyloid-β peptide receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer's disease. Proc Natl Acad Sci USA, 1997, 94:5296-5301 被引量:1
  • 10[10]Hao C, Guilbert LJ, Fedoroff S. Production of the colony stimulating factor- 1 receptor ( CSF- 1 R) by mouse astroglia in vitro. J Neurosci Res, 1997, 27:314-323 被引量:1

共引文献8

同被引文献15

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部